iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Shilpa Medicare Telangana facility gets Health Canada GMP approval

1 Dec 2022 , 09:16 AM

Shilpa Medicare

Shilpa Medicare Ltd’s finished dosage form manufacturing facility, Unit IV, situated at Pharma SEZ, Jadcherla, Telangana has received Health Canada GMP approval for the inspection conducted from September 12, 2022 to September 16, 2022.

The facility is involved in manufacturing, packaging, labelling and testing of finished dosage forms (sterile injections and oral solids) for the treatment of cancer and adjuvant therapy.

This GMP approval will allow the company for the commercial distribution of products in Canada and enable new application submissions to Health Canada.

This approval reaffirms the company’s focused efforts to maintain the GMP status up to the standards of global regulatory authorities.

At around 9:17 AM, Shilpa Medicare Ltd is currently trading at Rs300.85 per share up by Rs19.3 or 6.85% from its previous closing of Rs281.55 per share on the BSE.

For feedback and suggestions, write to us at editorial@iifl.com

Related Tags

  • announcement
  • API facility
  • Shilpa Medicare Ltd
  • Shilpa Medicare Ltd shares
  • Shilpa Medicare Ltd stocks
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.